Company Profile
Amphastar Pharmaceuticals, Inc. Stock Price, News & Catalysts
- Ticker:
- AMPH
- Exchange:
- NASDAQ
- Sector:
- Pharmaceuticals
- Location:
- United States
Stock performance
25.35 USD (-1.78%)
Close
Last updated: October 1, 2026
814M USD
Market cap
Why the stock is moving
As of Oct 1, 2026, AMPH closed down 1.78% at $25.35. No new same-company headline was identified in the current news window.
Company overview
Specialty Pharmaceutical Manufacturer
Amphastar Pharmaceuticals develops, manufactures, and commercializes technically challenging injectable, inhaled, intranasal, and other pharmaceutical products. Its portfolio combines proprietary brands, complex generics, active pharmaceutical ingredients, and selected biosimilar programs.
Proprietary Products
The company's branded products include BAQSIMI nasal glucagon, Primatene MIST, REXTOVY, Amphadase, and Cortrosyn. These products give Amphastar direct exposure to diabetes rescue, respiratory care, opioid overdose, diagnostic use, and other specialty markets.
Complex Generic Medicines
Amphastar supplies sterile injectables and other complex generics that require specialized development, manufacturing, and regulatory capabilities. Its products are distributed through wholesalers, retailers, hospitals, and group purchasing organizations.
Integrated Manufacturing and APIs
The company manufactures active pharmaceutical ingredients through its ANP subsidiary and operates finished-dose facilities for sterile and nonsterile products. Vertical integration supports supply control, product economics, and development of medicines with technically demanding formulations or devices.
Biosimilar and Proprietary Pipeline
The pipeline includes a filed biosimilar insulin candidate, an additional filed abbreviated new drug application, other biosimilar and generic programs, and in-licensed proprietary peptides for oncology and ophthalmology. Amphastar is also developing a fully synthetic corticotropin compound for inflammatory and autoimmune diseases.
Future catalysts
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Amphastar Pharmaceuticals, Inc. (AMPH)?
Amphastar Pharmaceuticals, Inc. (AMPH) most recently closed at 25.35 USD, a -1.78% move versus the previous session.
What is the market cap of Amphastar Pharmaceuticals, Inc. (AMPH)?
Amphastar Pharmaceuticals, Inc. currently has a market capitalization of 814M USD on BioPharmSignal.
What does Amphastar Pharmaceuticals, Inc. do?
Specialty Pharmaceutical Manufacturer Amphastar Pharmaceuticals develops, manufactures, and commercializes technically challenging injectable, inhaled, intranasal, and other pharmaceutical products. Its portfolio combines proprietary brands, complex generics, active pharmaceutical ingredients, and selected biosimilar programs. Proprietary Products The...
On which exchange is AMPH stock listed?
Amphastar Pharmaceuticals, Inc. (AMPH) is associated with NASDAQ, United States, Pharmaceuticals.
What is Specialty?
Specialty Pharmaceutical Manufacturer Amphastar Pharmaceuticals develops, manufactures, and commercializes technically challenging injectable, inhaled, intranasal, and other pharmaceutical products.
Which conditions is Amphastar Pharmaceuticals, Inc. targeting with Specialty?
Amphastar Pharmaceuticals, Inc. is associated with oncology, diabetes, respiratory disease based on its company overview and current catalyst commentary.
What is Pharmaceutical?
Specialty Pharmaceutical Manufacturer Amphastar Pharmaceuticals develops, manufactures, and commercializes technically challenging injectable, inhaled, intranasal, and other pharmaceutical products.
What is Manufacturer?
Specialty Pharmaceutical Manufacturer Amphastar Pharmaceuticals develops, manufactures, and commercializes technically challenging injectable, inhaled, intranasal, and other pharmaceutical products.